Global Action For Fungal Infections (GAFFI)’s Post

People living with HIV (#PLHIV) have a higher risk for non-communicable diseases (#NCDs) than those without HIV, including: ·        A two-fold increased risk of #cardiovasculardisease ·        Two times the likelihood of #depression ·        A higher risk of #type2diabetes ·        A higher risk of certain cancers, including #lymphoma and #cervicalcancer On #WorldAIDSDay, I invite you to explore a collection of 10 stories by PLHIV and NCDs. Through Viatris’ partnership with the NCD Alliance, this initiative highlights diverse, first-hand experiences of the barriers people face in managing conditions and accessing care. You can download the publication here to learn more: https://lnkd.in/e35HkT4t #viaviatris #ncdalliance #careintegration #worldaidsday

#Part1 #PublishedToday: The latest Global Health Sector Strategies Report of the World Health Organization (WHO) shows that while there has been a substantial increase in expanding service access for #HIV, #viralHepatitis and #SexuallyTransmittedInfections #STIs, 2.5 million people are still dying every year due to these three infections. Thus, these illnesses continue to pose a major global health challenge. In lead up to the world's largest AIDS conference this year - 25th International AIDS Conference or #AIDS2024 of International AIDS Society, there is a growing call to #PutPeopleFirst. People-centred responses grounded in human rights can help accelerate progress towards ending AIDS, viral hepatitis and STIs. Read an in-depth article based on an exclusive CNS interview with Dr Meg Doherty, WHO Director of the Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes. "We have the tools to be on the pathway to reach our 2025 targets and our 2030 goals." 🔷 The Sangai Express, India (part-1, op-ed page, 15 June 2024) https://lnkd.in/gsr7NEhZ 🔷 CNS https://lnkd.in/gysTxS2M #endAIDS #endhepatitis #endviralhepatitis #EndSTIs #viralhepatitis #hepatitis #HepatitisB #HepatitisBvirus #HepatitisC #HepatitisCVirus #HCV #HBV #SDGs #KeepThePromise #ItsTimeForAccountability #ItsTimeForAChange #MakeAdifference #BeTheChange #ChangeMakers #GlobalHealth #GlobalHealthSecurity #AntimicrobialResistance #AMR #Healthforall #AllforHealth

#PublishedToday: The latest Global Health Sector Strategies Report of the World Health Organization (WHO) shows that while there has been a substantial increase in expanding service access for #HIV, #viralHepatitis and #SexuallyTransmittedInfections #STIs, 2.5 million people are still dying every year due to these three infections. Thus, these illnesses continue to pose a major global health challenge. In lead up to the world's largest AIDS conference this year - 25th International AIDS Conference or #AIDS2024 of International AIDS Society, there is a growing call to #PutPeopleFirst. People-centred responses grounded in human rights can help accelerate progress towards ending AIDS, viral hepatitis and STIs. Read an in-depth article based on an exclusive CNS interview with Dr Meg Doherty, WHO Director of the Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes. "We have the tools to be on the pathway to reach our 2025 targets and our 2030 goals." 🔷 Daily GM Kashmir, India (full newspaper page, 15 June 2024) https://lnkd.in/g3ajtky8 🔷 CNS https://lnkd.in/gysTxS2M #endAIDS #endhepatitis #endviralhepatitis #EndSTIs #viralhepatitis #hepatitis #HepatitisB #HepatitisBvirus #HepatitisC #HepatitisCVirus #HCV #HBV #SDGs #KeepThePromise #ItsTimeForAccountability #ItsTimeForAChange #MakeAdifference #BeTheChange #ChangeMakers #GlobalHealth #GlobalHealthSecurity #AntimicrobialResistance #AMR #Healthforall #AllforHealth Andy Seale Carlos Andrés Cisneros

Join our live webinar tomorrow 6 June from 17H30 to 19H30 on Understanding Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) in People Living with HIV: A Comprehensive Approach - Register here: https://lnkd.in/d62yA3Up and register here : https://lnkd.in/dYgUzX9c for Tuesday 11 June - Pre-recorded with with live chat. Our expert presenters Dr. Nomathemba Chandiwana (Physician-Scientist) and Mrs Itumeleng Phiri (Specialist Radiographer) will empower your knowledge on MASLD, the latest term for non-alcoholic fatty liver disease (NAFLD), an important obesity-related condition, and one that remains poorly understood in South Africa. MASLD affects roughly 30% of the global adult population and contributing significantly to liver-related health issues yet is understudied in the context of HIV and obesity. Obesity and its complications among people living with HIV are currently facing significant challenges at the intersection of infectious and non-communicable diseases in South Africa. #HIV #healthcareprofessionals #obesity #changinglives

Meet Qure.ai's Enla Fees at the International AIDS Conference in Munich this week, and explore the impact of #AI solutions on the TB-HIV coinfection burden.    According to the World Health Organization, people living with HIV are most at risk of a fatal #TB infection, and 14 to 18 times more likely to get TB. It is critical in #healthcare programs for the two to go hand in hand.     People with HIV should be screened for TB, and vice versa. However, there remains a gap in many healthcare centres, where the two departments are separate or in different rooms, leading to patients being missed in the process.    At Qure, we are working towards integrated care pathways for healthcare providers, so they can access the best health-tech solutions and much-needed seamless support. To learn more about how you can integrate our TB care pathways into your HIV programs, reach out to us.     Let’s ensure no patient is left behind. Prashant Warier Dr. Pragnesh Pokar Sruti Sridhar Justy Antony Chiramal Mangesh Ashrit Shibu Vijayan Divya Gupta Dara Kelleher Ankit Modi Justy Antony Chiramal Bhargava Reddy Anumeha Srivastava Jai Bassi Yakhouba TOURÉ Ronika Susan George Kingshuk Misra Somesh Pathak Sanya Chawla Kautuk Trivedi Khalid Hegazy, MBA Saniya Pawar Suridhi Sharma Shreshth Bansal

In 2022, South Africa had one of the highest incidences of TB globally. An estimated 60% of new TB cases in SA are in persons with HIV. Drug-Induced Liver Injury (DILI) is the most common severe adverse drug reaction (ADR) of anti-tuberculous therapy. These factors contribute to the risk of anti-tuberculous drug-induced liver injury For detailed guidance on managing DILI in individuals with HIV undergoing tuberculosis treatment, please refer to/download the new comprehensive guideline: https://lnkd.in/d2_2Q-hB #TB #HIV #HealthcareProfessionals #ClinicalCare #ChangingLives

📢 Ensuring Accurate Diagnoses for Advanced HIV Disease (AHD) Management 🩺 A CD4 count of 200 cells/µL or below qualifies patients for Advanced HIV Disease (AHD) management, triggering vital tests like CrAg and TB LAM. However, when a machine has a measurement uncertainty of ±10%, a recorded CD4 count of 220 cells/µL could actually be 200 cells/µL or lower. ⚠️ This means patients may miss critical care due to equipment performance limitations. 🔍 What can we do? It's essential to integrate equipment performance stats into programming guidelines to ensure no patient is left behind. We're calling on accredited laboratories to join a data collection exercise aimed at improving diagnostics and publishing impactful findings. 📧 Contact us to participate and make a difference in AHD management. Together, we can bridge gaps in healthcare! 🤝 #HIVCare #AHDManagement #LabAccuracy #HealthInnovation #PatientSafety #BiolabsRedServices

#LastPart #PublishedToday: The latest Global Health Sector Strategies Report of the World Health Organization (WHO) shows that while there has been a substantial increase in expanding service access for #HIV, #viralHepatitis and #SexuallyTransmittedInfections #STIs, 2.5 million people are still dying every year due to these three infections. Thus, these illnesses continue to pose a major global health challenge. Read an in-depth article based on an exclusive CNS interview with Dr Meg Doherty, WHO Director of the Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes. "We have the tools to be on the pathway to reach our 2025 targets and our 2030 goals." In lead up to the world's largest AIDS conference this year - 25th International AIDS Conference or #AIDS2024 of IAS - International AIDS Society, there is a growing call to #PutPeopleFirst. People-centred responses grounded in human rights can help accelerate progress towards ending AIDS, viral hepatitis and STIs. 🔷 The Sangai Express, India (part-2, op-ed page, 16 June 2024) https://lnkd.in/grz-uBDR 🔷 CNS https://lnkd.in/gysTxS2M #endAIDS #endhepatitis #endviralhepatitis #EndSTIs #viralhepatitis #hepatitis #HepatitisB #HepatitisBvirus #HepatitisC #HepatitisCVirus #HCV #HBV #SDGs #KeepThePromise #ItsTimeForAccountability #ItsTimeForAChange #MakeAdifference #BeTheChange #ChangeMakers #GlobalHealth #GlobalHealthSecurity #AntimicrobialResistance #AMR #Healthforall #AllforHealth

The Division of Infectious Diseases announced a continuous quality improvement (CQI) project created to increase STD and mammography screening in HIV positive cis-female patients. The launch consists of four emails which reveal: 1. Stats of screening rates at UNC Eastowne Infectious Diseases Clinic 2. Explains why ID physicians need to order STI and mammogram screening. 3. Links to the specificity and sensitivity of self-swab STD testing in cis-female patients. 4. Explanation tof the new patient questionnaire that helps identify a patient who needs screening. Led by first-year infectious diseases fellow Gregory Rothchild, the CQI team chose to launch the project this month to coincide with Women’s History Month. 🔗 https://ow.ly/zPiA50R3nYZ #UNC #DeptofMed #unchealth #mammography #STD #healthscreenings #HIV #ContinuousQualityImprovement #CQI #healthproject #WomensHistoryMonth #WomensHealth

🌍 On #WorldAIDSDay, let’s highlight the impact of off-patent medicines in improving access to HIV prevention and treatment. 📉 Since 2016, new HIV infections in the EU have dropped by nearly 45% with the introduction of PrEP (pre-exposure prophylaxis). Yet, disparities have persisted. In Central and Eastern Europe (CEE), high costs and limited public reimbursement have slowed progress compared to Western Europe. ✅ In 2017, the introduction of generic PrEP made prevention more affordable, resulting in a 35% increase in PrEP use in CEE over the following five years. Such progress underscores the value of generic medicines in the fight against #HIV and other diseases as they: • Expand access to vulnerable populations. • Enable healthcare systems to make the most of their resources. • Indirectly improve public health by preventing disease transmission. 🔁 Let’s continue working for better #Access4All and policies that make generics part of the solution. #StopHIVTogether